Michal Elovitz, MD, discusses new preterm birth data at SMFM

Video

In this exclusive video interview, Michal Elovitz, MD, chief medical advisor at Mirvie, discusses the latest data from the RNA testing platform in predicting preterm birth at the SMFM 42nd Annual Pregnancy Meeting.

Michal Elovitz, MD

Michal Elovitz, MD

Michal Elovitz, MD is the Hilarie L. Morgan and Mitchell L. Morgan President’s Distinguished Professor in Women’s Health at the Perelman School of Medicine at the University of Pennsylvania and Chief Medical Advisor at Mirvie.

Recent Videos
Elinzanetant displays positive phase 3 safety and efficacy data against VMS | Image Credit: © toeytoey - © toeytoey - stock.adobe.com.
JoAnne Pinkerton, MD, FACOG, NCMP
Nannette Santoro, MD
The importance of nipocalimab’s FTD against FNAIT | Image Credit:  linkedin.com
Revolutionizing menopause management: A deep dive into fezolinetant | Image Credit: uvahealth.com.
How fezolinetant changes management of hot flashes | Image Credit: medschool.cuanschutz.edu.
Marco Taglietti
Related Content
© 2024 MJH Life Sciences

All rights reserved.